Compare ATYR & OTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | OTH |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 82.7M |
| IPO Year | 2015 | 2025 |
| Metric | ATYR | OTH |
|---|---|---|
| Price | $0.78 | $2.83 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 106.8K |
| Earning Date | 11-06-2025 | 12-15-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | $190,000.00 | ★ $105,737,814.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | N/A |
| P/E Ratio | ★ N/A | $52.88 |
| Revenue Growth | N/A | ★ 7.79 |
| 52 Week Low | $0.64 | $2.80 |
| 52 Week High | $7.29 | $3.90 |
| Indicator | ATYR | OTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | N/A |
| Support Level | $0.70 | N/A |
| Resistance Level | $0.83 | N/A |
| Average True Range (ATR) | 0.06 | 0.00 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 57.87 | 0.00 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Off The Hook YS Inc operates as a nationwide leader in the yacht and boat dealership industry, offering a comprehensive suite of services that spans the entire boat value chain. The company operates as two segments: Boat Sales and Azure Funding. Boat Sales includes Specializing in the buying, selling, and wholesaling of yachts and boats, having a boat dealership created to run Yellow Fin sales in Miami; and Azure Funding includes a recreational loan broker and lender providing financing solutions for individuals, dealerships, and brokerages.